16.06.22
Benzinga
In the days leading up to the recent bear market entry, cannabis insiders provided Benzinga with varied opinions regarding the impact of inflation on the cannabis sector.
Benzinga
As fears of skyrocketing inflation fueled the bear market, some remained optimistic about cannabis, even confident in some instances.
08.06.22
ABC NEWS
Thailand has become the first country in Asia to take marijuana off its list of banned substances and to allow people to grow the plant at home.
It’s a major policy shift in a country long known for its harsh drug controls, but the Thai government hopes the law change will boost the wellness and tourism industries.
03.06.22
Cannabis Wealth
Mike Sassano, CEO of European cannabis manufacturer Somai Pharmaceuticals, offers his perspective on Germany’s accelerated plans for adult-use cannabis legalisation.
01.06.22
Cannabis Law Report
In Good Manufacturing Practice (GMP) facilities, managing your stock is critical for Quality Assurance (QA). Your QA team needs to track the raw materials, ensure their correct use, and know potential losses, actual losses, and the products near or exceeding the expiration date
01.06.22
Cannabis Corner Podcast
This week Michael Sassano of Somai Pharmaceuticals , a Lisbon, Portugal based cannabis pharmaceutical manufacturer , joins the Corner to share his thoughts on Germany’s health minister embracing adult use cannabis, countries like Zimbabwe becoming large scale cannabis producers and he gives some insights on the question “How can cannabis pharmaceuticals and traditional/legacy cannabis coexist.”
17.05.22
YouTube – Somai Pharmaceuticals
Sequire Cannabis & Psychedelic Conference went live on April 20th with industry experts and investor 1:1s.
This 1-day virtual investor event was held via SRAX’s Sequire Virtual Events platform on April 20th, 2022. Nearly nine million active small-cap investors were invited to the event, which featured over 25 Cannabis & Psychedelic companies hosting 25 minute presentations, alongside keynotes highlighting prominent names in these spaces.
12.05.22
CannaList Conversations
We recently sat down with Michael Sassono – he is one of the most respected executives in the pharmaceutical cannabis space today. He was an early investor in the cannabis industry in the United States; today he is celebrated in mainstream business and biopharma media as an international authority on developing large-scale cannabis infrastructures throughout the world and the most advanced pharmaceutical cannabinoid products. Michael is also widely respected for successfully predicting long-term cannabis market trends and movements, which he generously shares in many forums.
10.05.22
Cannabis Wealth
Germany’s health minister Karl Lauterbach – who until last year was opposed to cannabis legalisation – said Germany’s coalition government will begin the legal process for cannabis legalisation sooner than planned.
09.05.22
YouTube – Somai Pharmaceuticals
Michael Sassano, CEO and Chairman, Somai Pharmaceuticals presented on Monday the 9th of May 2022 at 03:00pm on our SMART event platform with subject “Discussion of the Global Pharmaceutical Cannabis market and the history of recent growth”. CPhI SMART event platform is the perfect resource for gathering insights, networking and connecting with leading pharma players.